Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

GSK workers protest

Aptuit deal saves GSK’s R&D unit in Verona

July 5, 2010 Manufacturing and Production, Research and Development Aptuit, GlaxoSmithKline, Italy

GlaxoSmithKline has sold off its medicines research facility in Verona, Italy, to contract research and manufacturing service group Aptuit in …
News
Pfizer Oncology iPhone app

Digital Pharma: Big pharma’s iPhone apps (part one)

July 2, 2010 Medical Communications, Research and Development, Sales and Marketing Apple, Digital Pharma blog, app, digital pharma, ipad, iphone

Most sectors of business have been eagerly eyeing, and responding to, the potential of Apple’s iPhone, and this year’s iPad …
Feature

No sign of revival in R&D productivity

June 30, 2010 Research and Development drug development, industry, research

New data on the performance of the pharmaceutical industry shows efforts to raise productivity have not yet made an impact. …
News
Indian flag

US and India advance healthcare co-operation

June 30, 2010 Research and Development, Sales and Marketing India, h1n1, medical schools

The US and India are looking to establish closer ties between their top medical schools. The initiative was one of …
News

Sanofi acquires US biotech TargeGen

June 30, 2010 Research and Development Sanofi, TargeGen, haematology

Sanofi-Aventis is to buy TargeGen, a US biopharmaceutical company which develops small molecule kinase inhibitors. The drugs are used to …
News

Contract research news in brief

June 30, 2010 Research and Development CRO

Yet more geographic expansion from leading CROs, with Kendle opening an office in India and PRA International announcing a Hungarian …
News

Real World Development: Increasing value for patients

June 30, 2010 Research and Development Kinapse, drug development

The traditional drug development paradigm is protracted and costly, with many products failing to deliver commercial or clinical success.We propose …
Feature

Boehringer cheered by diabetes data

June 28, 2010 Research and Development Boehringer, DPP-4, diabetes, linagliptin

Boehringer Ingelheim has been cheered by phase III data showing its new oral once-daily type II diabetes tablet linagliptin significantly …
News

New anti-clotting drugs: stopping the silent killers

June 28, 2010 Research and Development, Sales and Marketing Pradaxa, VTE, Xarelto, atrial fibrilation, thrombosis

Blood clots are a major killer, but the threat they pose is poorly understood by the general public compared to …
Feature

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010 Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …
News

Merck moves tropical disease drug into phase II

June 25, 2010 Research and Development Chagas disease, Merck & Co, Noxafil, tropical disease

Merck & Co is to see whether its oral antifungal agent Noxafil (posaconazole) can be used in chronic cases of …
News

Clavis Pharma appoints Athos Gianella-Borradori

June 24, 2010 Research and Development Clavis Pharma, appointment, research and development

Athos Gianella-Borradori has joined clinical stage oncology drug development company Clavis Pharma as chief medical officer. His appointment to the …
Appointment

AstraZeneca and Targacept begin depression trials

June 24, 2010 Research and Development AstraZeneca, Targacept, depression

AstraZeneca and Targacept have begun enrolling patients in phase III trials for TC-5214, a new treatment for depression. The new …
News

Prix Galien shortlist unveiled

June 24, 2010 Research and Development prix galien

The shortlist of innovative medicines which will compete for two prestigious UK Prix Galien medals later this year has been …
News
UKCRMI

Plans for UK’s research hub unveiled

June 23, 2010 Research and Development Cancer Research UK, MRC, UCL, UKCMRI, Wellcome, biomedical

The vision for a new UK biomedical research and innovation centre which will be the biggest in Europe has been …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026